Swiss National Bank - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 352 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2020. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2023$335,580
-53.7%
98,7000.0%0.00%
Q2 2023$725,445
-27.7%
98,700
+1.9%
0.00%
-100.0%
Q1 2023$1,003,884
-20.7%
96,900
-9.6%
0.00%0.0%
Q4 2022$1,266,032
-43.7%
107,2000.0%0.00%
-50.0%
Q3 2022$2,250,000
-33.5%
107,200
-1.7%
0.00%0.0%
Q2 2022$3,383,000
-28.0%
109,000
-4.8%
0.00%
-33.3%
Q1 2022$4,701,000
+1.5%
114,500
+7.5%
0.00%0.0%
Q4 2021$4,630,000
-13.2%
106,5000.0%0.00%0.0%
Q3 2021$5,332,000
-19.9%
106,500
+0.8%
0.00%
-25.0%
Q2 2021$6,658,000
-30.4%
105,700
+2.6%
0.00%
-33.3%
Q1 2021$9,570,000
+5.0%
103,000
+1.3%
0.01%0.0%
Q4 2020$9,112,000
-12.7%
101,700
+0.7%
0.01%
-25.0%
Q3 2020$10,436,000
+33.7%
101,000
+2.3%
0.01%
+14.3%
Q2 2020$7,805,000
+58.5%
98,700
+16.0%
0.01%
+40.0%
Q1 2020$4,924,000
+8.8%
85,100
+1.4%
0.01%0.0%
Q4 2019$4,526,000
+5.2%
83,900
+1.9%
0.01%0.0%
Q3 2019$4,303,000
+10.0%
82,300
+1.6%
0.01%
+25.0%
Q2 2019$3,913,000
-1.8%
81,000
+2.7%
0.00%0.0%
Q1 2019$3,986,000
-10.6%
78,900
+4.9%
0.00%
-33.3%
Q4 2018$4,458,000
-7.5%
75,200
+2.7%
0.01%
+20.0%
Q3 2018$4,819,000
+30.4%
73,2000.0%0.01%
+25.0%
Q2 2018$3,696,000
+14.9%
73,200
+19.8%
0.00%0.0%
Q1 2018$3,217,000
+17.9%
61,100
+4.1%
0.00%
+33.3%
Q4 2017$2,728,000
+18.5%
58,700
+3.2%
0.00%0.0%
Q3 2017$2,302,000
+19.3%
56,9000.0%0.00%
+50.0%
Q2 2017$1,929,000
+16.8%
56,9000.0%0.00%0.0%
Q1 2017$1,652,000
-9.5%
56,900
+2.3%
0.00%
-33.3%
Q4 2016$1,826,000
+4.2%
55,6000.0%0.00%0.0%
Q3 2016$1,753,000
+5.3%
55,600
-6.1%
0.00%0.0%
Q2 2016$1,665,000
-14.9%
59,200
+6.5%
0.00%
-25.0%
Q1 2016$1,956,000
+8.7%
55,600
+23.6%
0.00%0.0%
Q4 2015$1,800,000
+40.4%
45,0000.0%0.00%
+33.3%
Q3 2015$1,282,000
-2.5%
45,000
+12.8%
0.00%0.0%
Q2 2015$1,315,000
+14.5%
39,9000.0%0.00%0.0%
Q1 2015$1,148,000
+5.7%
39,9000.0%0.00%
-25.0%
Q4 2014$1,086,000
+31.0%
39,900
+2.6%
0.00%
+33.3%
Q3 2014$829,000
-5.1%
38,9000.0%0.00%0.0%
Q2 2014$874,000
-7.8%
38,900
+3.7%
0.00%
-25.0%
Q1 2014$948,000
+37.0%
37,500
+24.6%
0.00%
+33.3%
Q4 2013$692,000
+20.8%
30,1000.0%0.00%
+50.0%
Q3 2013$573,000
+27.1%
30,100
-3.8%
0.00%0.0%
Q2 2013$451,00031,3000.00%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Zebra Capital Management LLC 22,111$908,0002.08%
Global Alpha Capital Management Ltd. 460,530$18,909,0001.62%
AIMZ Investment Advisors, LLC 70,625$2,900,0001.19%
Bridge City Capital, LLC 39,835$1,636,0000.76%
PALISADE CAPITAL MANAGEMENT, LP 560,409$23,010,0000.53%
EARNEST PARTNERS LLC 2,071,376$85,051,0000.50%
RICE HALL JAMES & ASSOCIATES, LLC 302,721$12,430,0000.50%
SummerHaven Investment Management, LLC 14,476$594,0000.34%
Ridgewood Investments LLC 10,004$411,0000.27%
AtonRa Partners 11,505$472,0000.26%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders